MacroGenics officer proposes sale of 31,105 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MacroGenics Inc. officer Jeffrey Peters reported a proposed sale of 31,105 common shares, with an aggregate market value of $129,145 and an approximate sale date of August 19, 2026. The notice lists 63,700,187 common shares outstanding and gives May 20, 2026, as the date of plan adoption or instruction for Rule 10b5-1 reliance.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Aggregate Market Value financial
Stock plan activity financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.